Merus N.V. (MRUS)
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.
Address
YALELAAN 62
3584 CM UTRECHT, P7 3584 CM
Founded
2003
Number of Employees
229
Website
http://www.merus.nl
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)